{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:30:10Z","timestamp":1786116610635,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bmc.2026.118751","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:24:59Z","timestamp":1783639499000},"page":"118751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery and biological evaluation of HS13 as a novel covalent ligand targeting the NSD2-PWWP1 domain"],"prefix":"10.1016","volume":"141","author":[{"given":"Chang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118751_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41586-025-09299-y","article-title":"NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers","volume":"649","author":"Jeong","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118751_bb0010","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1021\/acs.jmedchem.1c01116","article-title":"Targeting the nuclear receptor-binding SET domain family of histone lysine methyltransferases for cancer therapy: recent progress and perspectives","volume":"64","author":"Shrestha","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118751_bb0015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2305684120","article-title":"Tiam1 methylation by NSD2 promotes Rac1 signaling activation and colon cancer metastasis","volume":"120","author":"Song","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2026.118751_bb0020","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1038\/s41467-018-07511-4","article-title":"NSD2 is a conserved driver of metastatic prostate cancer progression","volume":"9","author":"Aytes","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2026.118751_bb0025","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-22-3481","article-title":"Histone methyltransferase NSD2 activates PKCalpha to drive metabolic reprogramming and lenalidomide resistance in multiple myeloma","volume":"83","author":"Chong","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2026.118751_bb0030","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1016\/j.molcel.2021.08.034","article-title":"NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis","volume":"81","author":"Sengupta","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2026.118751_bb0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2024.01.007","article-title":"Advances in inhibitor development targeting the PWWP domain","volume":"45","author":"Huang","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2026.118751_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116965","article-title":"Inhibitors targeting the PWWP domain-containing proteins","volume":"280","author":"Huang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118751_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115232","article-title":"Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: An update and perspectives","volume":"250","author":"Zhang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118751_bb0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41589-021-00898-0","article-title":"A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization","volume":"18","author":"Dilworth","year":"2022","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmc.2026.118751_bb0055","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/acs.jmedchem.0c01768","article-title":"Discovery of small-molecule antagonists of the PWWP domain of NSD2","volume":"64","author":"Ferreira de Freitas","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118751_bb0060","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1021\/acs.jmedchem.2c00709","article-title":"Structure-based discovery of a series of NSD2-PWWP1 inhibitors","volume":"65","author":"Li","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118751_bb0065","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1021\/acs.jmedchem.2c00807","article-title":"Discovery of a first-in-class degrader for nuclear receptor binding SET domain protein 2 (NSD2) and Ikaros\/Aiolos","volume":"65","author":"Meng","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118751_bb0070","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1021\/jacs.3c01421","article-title":"Discovery of a potent and selective targeted NSD2 degrader for the reduction of H3K36me2","volume":"145","author":"Hanley","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2026.118751_bb0075","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1021\/acs.jmedchem.3c01765","article-title":"Discovery of LLC0424 as a potent and selective in vivo NSD2 PROTAC degrader","volume":"67","author":"Liu","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118751_bb0080","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41589-024-01660-y","article-title":"Recruitment of FBXO22 for targeted degradation of NSD2","volume":"20","author":"Nie","year":"2024","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmc.2026.118751_bb0085","doi-asserted-by":"crossref","first-page":"24953","DOI":"10.1021\/acs.jmedchem.5c01902","article-title":"Fragment-based screening of NSD2-PWWP1 identifies novel covalent allosteric ligands that diminish methyllysine and DNA binding abilities of NSD2","volume":"68","author":"Huang","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118751_bb0090","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2403330121","article-title":"Targeted degradation of Pin1 by protein-destabilizing compounds","volume":"121","author":"Alboreggia","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2026.118751_bb0095","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1021\/acs.jmedchem.1c02007","article-title":"Cov_DOX: a method for structure prediction of covalent protein-ligand bindings","volume":"65","author":"Wei","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118751_bb0100","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1021\/acs.jcim.9b01197","article-title":"Cov_FB3D: a De novo covalent drug design protocol integrating the BA-SAMP strategy and machine-learning-based synthetic tractability evaluation","volume":"60","author":"Wei","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2026.118751_bb0105","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1021\/acs.jctc.8b01150","article-title":"Conformation search across multiple-level potential-energy surfaces (CSAMP): a strategy for accurate prediction of protein-ligand binding structures","volume":"15","author":"Wei","year":"2019","journal-title":"J Chem Theory Comput"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:22:23Z","timestamp":1786015343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"alternative-id":["S0968089626002075"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118751","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and biological evaluation of HS13 as a novel covalent ligand targeting the NSD2-PWWP1 domain","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118751"}}